Department of Critical Care, Pushpagiri Medical College Hospital, Thiruvalla, Kerala, India.
Department of Nephrology, Pushpagiri Medical College Hospital, Thiruvalla, Kerala, India.
Indian J Med Res. 2024 Jan 1;159(1):102-108. doi: 10.4103/ijmr.ijmr_2733_21. Epub 2024 Mar 4.
Rhabdomyolysis in tropics has a unique aetiology and clinical profile. The objective of this study was to determine the aetiology and clinical outcomes of rhabdomyolysis and validate the McMahon risk prediction score in affected individuals from south India.
A retrospective study of affected individuals with rhabdomyolysis admitted to a tertiary care hospital in south India, between January 2015 and June 2020, was undertaken. In-patients who were ≥15 yr in age and had creatinine phosphokinase ≥5000 U/l were included in the study. Cardiac, stroke, chronic muscular diseases and chronic kidney disease on maintenance haemodialysis were excluded. The incidence of acute kidney injury (AKI) in this group was calculated. Other clinical outcomes determined were 28-day mortality, proportion of individuals who required renal replacement therapy (RRT), intensive care unit (ICU) admission, vasopressors, mechanical ventilation (MV), number of days on mechanical ventilator and length of stay in ICU and hospital. Validation of McMahon risk prediction score for the requirement of RRT and mortality was performed.
Major aetiologies identified in the 75 study participants included were infections, trauma and seizures. Twenty eight-day mortality was 24 per cent (n=18). AKI incidence was 68 per cent, out of which 43.1 per cent had RRT. AKI in all survivors became dialysis independent. Vasopressors, MV and ICU requirement were 30.7, 32 and 77.3 per cent, respectively. Receiver operator characteristic curve for RRT and mortality risk prediction based on the McMahon Score showed a sensitivity of 71.4 per cent and specificity of 77.8 per cent for a cut-off ≥7.8.
Rhabdomyolysis in tropics is associated with significant organ dysfunction and mortality. Although the incidence of AKI and RRT is high, the overall renal outcome is good among survivors. The wide confidence intervals for the area under curve for McMahon Score limit its predictability for RRT and mortality.
热带地区横纹肌溶解症具有独特的病因和临床特征。本研究的目的是确定横纹肌溶解症的病因和临床结局,并验证来自印度南部的患者的 McMahon 风险预测评分。
对 2015 年 1 月至 2020 年 6 月期间在印度南部一家三级护理医院住院的横纹肌溶解症患者进行回顾性研究。纳入研究的患者年龄≥15 岁,肌酸磷酸激酶≥5000 U/l。排除心脏、中风、慢性肌肉疾病和维持性血液透析的慢性肾病。计算该组急性肾损伤(AKI)的发生率。确定的其他临床结局包括 28 天死亡率、需要肾脏替代治疗(RRT)的个体比例、重症监护病房(ICU)入院、血管加压素、机械通气(MV)、机械通气天数和 ICU 及住院时间。对 McMahon 风险预测评分预测 RRT 和死亡率的准确性进行了验证。
在 75 名研究参与者中,主要病因包括感染、创伤和癫痫发作。28 天死亡率为 24%(n=18)。AKI 发生率为 68%,其中 43.1%需要 RRT。所有幸存者的 AKI 均转为透析独立。血管加压素、MV 和 ICU 需求分别为 30.7%、32%和 77.3%。基于 McMahon 评分的 RRT 和死亡率风险预测的受试者工作特征曲线显示,≥7.8 的截断值的敏感性为 71.4%,特异性为 77.8%。
热带地区的横纹肌溶解症与显著的器官功能障碍和死亡率相关。尽管 AKI 和 RRT 的发生率较高,但幸存者的整体肾脏结局良好。McMahon 评分的曲线下面积的置信区间较宽,限制了其对 RRT 和死亡率的预测能力。